Skip to main content
. 2015 Feb 28;35(8):1325–1333. doi: 10.1007/s00296-015-3235-z

Fig. 3.

Fig. 3

The relative improvement in DAS following GC bridging therapy in relation to GLCCI1 gene polymorphisms. Percentual improvement in DAS after 2 weeks of standardized GC treatment in all patients (a) male patients (b) and female patients (c). Error bars represent standard error of the mean (SEM); adjusted for use of NSAIDs